Moreover, in colorectal cancer cells, nucleus accumbens-associated protein 1 (Nac1) expression is elevated, which leads to an increase in drug resistance by upregulating Hoxa9 expression (Ju et al., 2017). The gene discussed is NACC1; the disease is colorectal cancer.